The Joint Blog

JUNE 4, 2021

The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. The DEA feels that marijuana, being a schedule I drug, could be misused like other drugs within that category and could be dangerous. Cachexia or wasting syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Canna Law Blog

JUNE 13, 2023

Drug Enforcement Administration (DEA) to implement and enforce the relevant provisions of the Controlled Substances Import and Export Act which makes it a crime to bring controlled substances into the country without a proper license. CBP coordinates with a wide range of partner government agencies (e.g., FDA, EPA, DOT, ATF, CPSC, etc.)

DEA 63

DEA Marijuana Hemp Concentrates 63

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions. Cannabis offers significant therapeutic benefits for a wide range of medical conditions. 5 cannabis strains to treat PTSD: 1.

Strains 190

Strains Indica Hybrid Research and Development 190

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 93

Research and Development Chronic Pain Treatment Medicine 93

Cannabis Law Report

NOVEMBER 20, 2021

he Alabama State Board of Medical Examiners Thursday announced draft rules to govern how physicians can recommend medical cannabis to eligible patients. The draft rules were developed in accordance with the state’s new law on medical cannabis, which was approved earlier this year by the state Legislature and signed into law by the governor.

Patients 52

Patients DEA Dispensary Conditions 52

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

AUGUST 18, 2022

Smith , a partner with the firm and co-leader of the firm’s Life Sciences & Health Effects Team, will lead the practice, bringing together scientist-attorneys and experienced litigators to support clients that are driving innovation in mental health treatments. Tweet this. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Conclusion. Source: [link].

Therapy 52

Therapy Patients Law Clinical Trials 52

CannaMD

AUGUST 8, 2020

– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!

CBD 99

CBD DEA Research and Development Hemp 99

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

MedicalJane

JUNE 29, 2018

At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Do you qualify for medical cannabis? There is no universal handbook for a medical cannabis program. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

CannaMD

NOVEMBER 20, 2020

Making matters worse, there’s only one farm in the entire country with DEA approval to cultivate marijuana for research purposes. A study by the American Medical Association found that 13% of workers experience a loss in productive time due to common pain conditions over a 2-week period. Cannabis vs. Opioids. More Cannabis.

Therapy 79

Therapy Treatment DEA CBD 79

The Cannigma

MAY 1, 2023

According to the DEA, “substances in this schedule have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.” Brain plasticity is basically the brain’s ability to adapt to stress, trauma, and injury. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Id ; 21 CFR 312.1-10; 10; 312.80-88; 88; 312.300 et seq.

Law 105

Law Therapy Clinical Trials Research and Development 105

The Blunt Truth

OCTOBER 3, 2019

Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Cannabis Law Report

JUNE 20, 2019

The marijuana or cannabis plant contains more than 400 different chemicals and 60 cannabinoid compounds, all of which are absorbed when the whole leaf is smoked or ingested. Please also be aware that no special issuances have been granted for conditions treated with medical marijuana. Source: [link].

THC 74

THC CBD Oil DEA 74

Cannabis Law Report

APRIL 14, 2022

Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country. by eating or smoking cannabis) are unknown. Since growing cannabis has not always been legal, growers did not always choose pesticides that were “approvable” by EPA.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

AUGUST 23, 2021

The trend toward state-level legalization of cannabis has led to a surge in cannabis-derived products and a continually evolving market with many types of cannabis products for people as well as their pets. Parts of the Cannabis plant have been controlled under the Controlled Substances Act (CSA) since 1970 [21 U.S.C

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. In light of this, the Drug Enforcement Administration (DEA) has announced its intention to substantially increase the production quota of psychedelics such as LSD, psilocybin, and mescaline due to be studied in 2023. .

Research and Development 79

Research and Development Therapy Consumption DEA 79

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Veriheal

MARCH 11, 2021

The Drug Enforcement Administration, or the DEA, explains that these types of drugs are also known as new psychoactive substances (NPS) and goes on to state that there are at least 300 known designer drugs, each of which belongs to one of the following three categories of NPS. Cannabis-Based Designer Drugs. Synthetic Phenethylamines.

Cannabinoids 52

Cannabinoids DEA Terpenes Packaging 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

MedicalJane

OCTOBER 5, 2017

Standard treatment for severe cramps and pain. An over-the-counter medication like Midol, or an NSAID like ibuprofen, are conventional treatments that are commonly used to treat mild symptoms of menstrual cramps. So where are women to turn for natural, alternative forms of treatment that may provide relief?

Marijuana 65

Marijuana Treatment Extraction Medicine 65

Alchimia

APRIL 17, 2018

As research on the different cannabinoids and terpenes – and other compounds produced by the cannabis plant – advances, more and more testimonies claim that the efficacy of these substances is beyond doubt. Cannabis can help our pets to have a healthier life. The endocannabinoid system of animals.

Pets 75

Pets CBD Cannabinoids Terpenes 75

The Blunt Truth

OCTOBER 24, 2019

Turns out, they were trying to get into cannabis in Florida as well. Let’s start in the northeast, where the governors of four states (New York, New Jersey, Connecticut and Pennsylvania) met to discuss coordinating their states’ cannabis policies. Cannabis research was also a big topic. See you next week!

Hemp 58

Hemp DEA CBD Topical 58

Cannabis Law Report

MAY 31, 2022

Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Though, Oregon is actively in the process of establishing a model for psilocybin that would be like the state’s current medical cannabis system. On March 5, 2019, the U.S.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

SEPTEMBER 20, 2019

They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Battle heating up over Florida ballot initiative to legalize cannabis for adult use.

Vaping 40

Vaping Banking Research and Development DEA 40

CannaMD

MAY 6, 2020

Just like using medical marijuana in residential apartments , traveling with cannabis comes down to federal versus state law. Since federal law supersedes state law, this also means that taking cannabis across state lines (even if both states permit medical marijuana use) is illegal. In practice, however, it’s very ambiguous.

Hash 103

Hash Legalization Marijuana Concentrates 103

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. They are responsible for giving you information about the treatment and proper use. The physician will conduct an evaluation to determine if your medical condition can improve with marijuana use. Who Monitors This Program in Oklahoma?

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. They are responsible for giving you information about the treatment and proper use. The physician will conduct an evaluation to determine if your medical condition can improve with marijuana use. Who Monitors This Program in Oklahoma?

Marijuana 52

Marijuana Patients Conditions Programs 52

CannaMD

SEPTEMBER 10, 2020

Is it safe to continue cannabis-based therapies during pregnancy? In the mid-20th century era of “reefer madness,” the mainstream view on cannabis and pregnancy was clear: expecting mothers who used marijuana were considered ‘derelict’ and in some cases criminally negligent for the endangerment of their unborn child.

Marijuana 59

Marijuana Therapy Data THC 59

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The lawsuit came after the DEA denied their application to utilize a synthetic form of psilocybin under the RTT laws.

Therapy 53

Therapy DEA Patients Clinical Trials 53

Canna Law Blog

NOVEMBER 6, 2021

The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). But federal lawsuits on cannabis rescheduling provide guidance and suggest that FDA approval is not a requirement for meeting that criterion. Last week in Nature Medicine , I.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98